We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Depressive

News List

Psychotherapy Alone First Line of Treatment for Depressed Youth drugs
August 13, 2019
Cognitive behavioral therapy (CBT) should be the first line of treatment in younger patients with major depressive disorder before clinicians prescribe medication...
Intra-Cellular Therapies Announces Positive Phase III Results contractpharma
July 17, 2019
Lumateperone achieves topline results in the treatment of major depressive episodes associated with Bipolar I or Bipolar II disorder.
Studies Look at Ways to Reduce Depressive Episodes in Obese drugs
March 06, 2019
For overweight adults with depression, daily multinutrient supplements and individual or group therapy sessions do not reduce major depressive disorder (MDD) episodes over one year...
Newly Published Phase 2 Study Found Esketamine Demonstrated Significantly Rapid Improvements in Depressive Symptoms and Suicidality biospace
April 17, 2018
Johnson & Johnson Jansen pharmaceutical company announced today, from a concept of a concept of ketamine nasal spray in the clinical study phase 2, published in the American Journal of psychiatry.

Previous page 1 2 Next page